| Literature DB >> 32182217 |
Neha Shrestha1, Tongyu Liu2,3, Yewei Ji1, Rachel B Reinert4, Mauricio Torres1, Xin Li5, Maria Zhang6, Chih-Hang Anthony Tang7, Chih-Chi Andrew Hu7, Chengyang Liu8, Ali Naji8, Ming Liu4,5, Jiandie D Lin2,3, Sander Kersten9, Peter Arvan1,4, Ling Qi1,4.
Abstract
β Cell apoptosis and dedifferentiation are 2 hotly debated mechanisms underlying β cell loss in type 2 diabetes; however, the molecular drivers underlying such events remain largely unclear. Here, we performed a side-by-side comparison of mice carrying β cell-specific deletion of ER-associated degradation (ERAD) and autophagy. We reported that, while autophagy was necessary for β cell survival, the highly conserved Sel1L-Hrd1 ERAD protein complex was required for the maintenance of β cell maturation and identity. Using single-cell RNA-Seq, we demonstrated that Sel1L deficiency was not associated with β cell loss, but rather loss of β cell identity. Sel1L-Hrd1 ERAD controlled β cell identity via TGF-β signaling, in part by mediating the degradation of TGF-β receptor 1. Inhibition of TGF-β signaling in Sel1L-deficient β cells augmented the expression of β cell maturation markers and increased the total insulin content. Our data revealed distinct pathogenic effects of 2 major proteolytic pathways in β cells, providing a framework for therapies targeting distinct mechanisms of protein quality control.Entities:
Keywords: Beta cells; Cell Biology; Diabetes; Metabolism; Protein misfolding
Mesh:
Substances:
Year: 2020 PMID: 32182217 PMCID: PMC7324191 DOI: 10.1172/JCI134874
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808